🔎 Trials Near Me

Akèy › Leksemi limfoblastik egi › Oklahoma › Oklahoma City

Etid klinik pou Leksemi limfoblastik egi nan Oklahoma City, OK

6 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mercy Hospital Oklahoma City, Oklahoma City
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Ap rekriteEtid obsèvasyon
  • Board of Regents of the University of Oklahoma Health Sciences Center, Oklahoma City
1 Day – 17 Years · Tout sèks · Mizajou Aug 14, 2026 · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • University of Oklahoma Health Science Center, Oklahoma City
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • University of Oklahoma Health Sciences Center, Oklahoma City
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

Pilot Imaging Study of Leukemia

Ap rekriteFaz 1
  • University of Oklahoma Health Sciences Center, Oklahoma City
Laj 4 a 80 · Tout sèks · Mizajou Apr 23, 2026 · NCT03633955

Etid Leksemi limfoblastik egi nan lòt vil

Lòt etid nan Oklahoma City

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.